RCUS Similar Chart Price Prediction
The price of RCUS is predicted to go up -37.14%, based on the high correlation periods with PT. The similarity of these two price pattern on the periods is 97.11%.
RCUS
PT
Down: -37.14%Similarity: 97.11%
RCUS Revenue Forecast
RCUS EPS Forecast
RCUS FAQs
What is RCUS revenue forecast for next quarter？
What is RCUS eps forecast for next quarter？
RCUS Analyst's Forecast
Peter Lawson
Barclays
Buy
2024-10-25
Price Target
$25 → $29
Upside
+77.7%
Barclays analyst Peter Lawson raised the firm's price target on Arcus Biosciences to $29 from $25 and keeps an Overweight rating on the shares. While the HIF2alpha data confirmed overall response rate is in line with Merck, there are multiple paths to higher rate with five patients still on study, the analyst tells investors in a research note.
